MediWound Ltd. (MDWD)
NASDAQ: MDWD · IEX Real-Time Price · USD
18.60
-2.29 (-10.96%)
At close: Jul 19, 2024, 4:00 PM
18.70
+0.10 (0.54%)
Pre-market: Jul 22, 2024, 7:00 AM EDT

MediWound Revenue

MediWound had revenue of $19.85M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $4.96M with 30.67% year-over-year growth. In the year 2023, MediWound had annual revenue of $18.69M.

Revenue (ttm)
$19.85M
Revenue Growth
-23.32%
P/S Ratio
8.70
Revenue / Employee
$198,510
Employees
100
Market Cap
172.67M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202318.69M-7.81M-29.48%
Dec 31, 202226.50M2.73M11.50%
Dec 31, 202123.76M2.00M9.19%
Dec 31, 202021.76M-10.03M-31.54%
Dec 31, 201931.79M28.39M834.70%
Dec 31, 20183.40M905.00K36.26%
Dec 31, 20172.50M938.00K60.21%
Dec 31, 20161.56M957.00K159.23%
Dec 31, 2015601.00K342.00K132.05%
Dec 31, 2014259.00K--
Dec 31, 20130--
Dec 31, 20120--
Dec 31, 20110--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accuray 430.55M
Puma Biotechnology 226.63M
Rigel Pharmaceuticals 120.35M
Innate Pharma 68.49M
Metagenomi 47.26M
Fennec Pharmaceuticals 44.95M
Revenue Rankings